TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Carisma Therapeutics ( (CARM) ) has issued an announcement.
Carisma Therapeutics Inc. has entered into a master services agreement with Danforth Global, Inc. and Danforth Advisors, LLC to receive finance and accounting services from Natalie McAndrew, who will serve as the interim Vice President of Finance and principal financial officer. This strategic appointment is expected to bolster the company’s financial management capabilities, enhancing its operational efficiency and potentially impacting its industry standing positively.
More about Carisma Therapeutics
YTD Price Performance: -86.38%
Average Trading Volume: 222,366
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $16.66M
See more insights into CARM stock on TipRanks’ Stock Analysis page.